| Item Type | Name |
|
Academic Article
|
T cell receptor repertoire of CD4+ and CD8+ T cell subsets in the allogeneic bone marrow transplant recipient.
|
|
Academic Article
|
Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors.
|
|
Academic Article
|
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes.
|
|
Academic Article
|
Graft-versus-host reactions and bone-marrow transplantation.
|
|
Academic Article
|
Current status of genetic modification of T cells for cancer treatment.
|
|
Academic Article
|
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
|
|
Academic Article
|
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.
|
|
Academic Article
|
Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.
|
|
Academic Article
|
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.
|
|
Academic Article
|
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells.
|
|
Academic Article
|
Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma.
|
|
Academic Article
|
T cell therapy in allogeneic stem cell transplantation.
|
|
Academic Article
|
Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy.
|
|
Academic Article
|
Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.
|
|
Academic Article
|
HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.
|
|
Academic Article
|
CARs on track in the clinic.
|
|
Academic Article
|
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.
|
|
Academic Article
|
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells.
|
|
Academic Article
|
Ex vivo gene transfer for improved adoptive immunotherapy of cancer.
|
|
Academic Article
|
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
|
|
Academic Article
|
Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.
|
|
Academic Article
|
Reconstitution of the T cell receptor alpha beta repertoire in recipients of allogeneic BMT.
|
|
Academic Article
|
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation.
|
|
Academic Article
|
The t(9;22) translocation in Philadelphia-positive essential thrombocythaemia does not involve the T lymphocyte lineage.
|
|
Academic Article
|
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation.
|
|
Academic Article
|
Adoptive T cell therapy of cancer.
|
|
Academic Article
|
Safer CARS.
|
|
Concept
|
Receptors, Antigen
|
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
T-Cell Antigen Receptor Specificity
|
|
Concept
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
|
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
|
Academic Article
|
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy.
|
|
Academic Article
|
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.
|
|
Academic Article
|
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15.
|
|
Academic Article
|
Kinetics of tumor destruction by chimeric antigen receptor-modified T cells.
|
|
Academic Article
|
Immunotherapy: opportunities, risks and future perspectives.
|
|
Academic Article
|
Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity.
|
|
Academic Article
|
Survivin-specific T cell receptor targets tumor but not T cells.
|
|
Academic Article
|
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.
|
|
Academic Article
|
CMV-specific T cells generated from na?ve T cells recognize atypical epitopes and may be protective in vivo.
|
|
Academic Article
|
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs.
|
|
Academic Article
|
CAR-T Cell Therapy for Lymphoma.
|
|
Academic Article
|
Clinical responses with T lymphocytes targeting malignancy-associated ? light chains.
|
|
Academic Article
|
Forecasting Cytokine Storms with New Predictive Biomarkers.
|
|
Academic Article
|
Checkpoint inhibition and cellular immunotherapy in lymphoma.
|
|
Academic Article
|
Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer.
|
|
Academic Article
|
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
|
|
Academic Article
|
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.
|
|
Academic Article
|
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
|
|
Academic Article
|
The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma.
|
|
Academic Article
|
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
|
|
Grant
|
Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT
|
|
Grant
|
ENHANCING T CELL THERAPY OF CANCER
|
|
Academic Article
|
In?Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.
|
|
Academic Article
|
Adoptive Immunotherapy with Antigen-Specific T Cells Expressing a Native TCR.
|
|
Academic Article
|
Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells.
|
|
Academic Article
|
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).
|
|
Academic Article
|
T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.
|
|
Academic Article
|
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
|
|
Academic Article
|
T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells.
|
|
Academic Article
|
Engineered off-the-shelf therapeutic T cells resist host immune rejection.
|
|
Academic Article
|
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma.
|
|
Academic Article
|
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
|
|
Academic Article
|
Beyond CD19 CAR-T cells in lymphoma.
|
|
Academic Article
|
Tumor-intrinsic causes of CAR-T failure.
|
|
Academic Article
|
Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies.
|
|
Academic Article
|
Introduction to a How I Treat series on emergent CAR T-cell toxicities.
|